Texas Capital Bancshares’s Bristol-Myers Squibb BMY Stock Holding History

Texas Capital Bancshares’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$82.9K	Buy	+1,838	New	+$85.8K	0.03%	95
2023 Q4	–	Sell	-3,607	Closed	-$209K	–	81
2023 Q3	$209K	Buy	3,607 +11	+0.3%	+$674	0.12%	82
2023 Q2	$230K	Sell	3,596 -117	-3%	-$7.85K	0.13%	80
2023 Q1	$257K	Buy	3,713 +67	+2%	+$4.73K	0.16%	75
2022 Q4	$262K	Hold	3,646	–	–	0.18%	73
2022 Q3	$259K	Hold	3,646	–	–	0.21%	66
2022 Q2	$281K	Buy	+3,646	New	+$278K	0.21%	65

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Texas Capital Bancshares's BMY Position: Q3 2025 in Review

Texas Capital Bancshares opened a new position in Bristol-Myers Squibb (BMY) in Q3 2025: 1,838 shares worth $82.9K. The stake represents 0.03% of the portfolio and ranks #95 among its holdings. This is a return to the name: Texas Capital Bancshares previously reported a position in BMY as recently as Q3 2023.

Texas Capital Bancshares first reported a position in BMY in Q2 2022 and has held it in 7 quarters since. The position peaked at $281K in Q2 2022. 2,268 funds tracked by Wall St. Rank hold BMY as of Q3 2025.

Texas Capital Bancshares held 1,838 shares of Bristol-Myers Squibb worth $82.9K as of Q3 2025.
Bristol-Myers Squibb was a new Texas Capital Bancshares position in Q3 2025.
Bristol-Myers Squibb made up 0.03% of Texas Capital Bancshares's portfolio in Q3 2025, its #95 holding.
Texas Capital Bancshares first reported a position in Bristol-Myers Squibb in Q2 2022 and has held it in 7 quarters since.
Texas Capital Bancshares's Bristol-Myers Squibb position peaked at $281K in Q2 2022.
2,268 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2025.

Based on Texas Capital Bancshares's 13F filing for Q3 2025, filed 13 Nov 2025.